Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small bubble of air inside a Mounjaro KwikPen is normal and does not mean the pen is faulty or the dose is unsafe. The pen is designed to hold a tiny air space, and seeing it — usually as you look at the cartridge window — is one of the most common questions our prescribers receive about the Mounjaro injectable pen. As a prescription-only medicine, your ongoing use of it should always be guided by your prescribing team and the Patient Information Leaflet supplied with each pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've taken your Mounjaro pen from the fridge (the back of the fridge shelf, probably, wedged between leftovers), let it sit for thirty minutes to reach room temperature, and then noticed something moving in the cartridge window when you tilted it. A small bubble. It looks wrong. It probably isn't.
The Mounjaro KwikPen is a pre-filled, multi-dose device. Each pen contains four weekly doses of tirzepatide, a dual GIP and GLP-1 receptor agonist licensed in the UK for weight management. Eli Lilly engineers a small air space into the cartridge deliberately, it accommodates pressure changes during transport and storage, particularly when pens move between temperatures. The tirzepatide SmPC on the electronic Medicines Compendium confirms that a small bubble in the liquid is normal and harmless for a subcutaneous injection.
Subcutaneous injections go under the skin, into fatty tissue. This matters because the concern most people have about air bubbles comes from their association with intravenous injections, where a meaningful volume of air entering a vein could be dangerous. A tiny bubble injected subcutaneously poses no equivalent risk. It disperses harmlessly.
One practical note: if you want to understand more about bubbles in your Mounjaro pen, including why they form and what sizes are considered normal, it helps to know that pens stored in a bag rather than a fridge, or taken on a longer journey than usual (say, the bank holiday order that arrived a day late), can develop slightly larger bubbles from temperature variation. That is still generally fine, but do check that the liquid remains clear and colourless before injecting.
Seeing a Mounjaro air bubble does not mean the pen is counterfeit, damaged, or that a dose has leaked out. These are the three conclusions people tend to jump to, and they're understandable, you're handling an expensive prescription medicine and you want to be sure it's right.
The liquid in a Mounjaro pen should be clear or very slightly yellow and free of visible particles. Those are the indicators that actually matter when you inspect a pen before use. A bubble sitting within that clear liquid is structural, not a sign of contamination or loss.
It also does not mean you should try to remove the bubble. If you are wondering what air bubbles in your Mounjaro pen actually require you to do, the short answer is nothing: the KwikPen is factory-set to deliver precise doses, and there is no user-facing priming step of the kind you'd perform with some insulin pens. If you attempt to dial back the dose counter and depress the plunger to expel air, you will waste medication and likely receive an inaccurate dose at your actual injection. Leave the bubble alone.
The NHS's patient information on tirzepatide and the instructions supplied in the box both walk through the injection steps in detail. Following those instructions precisely (without improvising) is the safest approach. If you're at all uncertain about how to use the pen correctly, the Mounjaro injection guide covers the technique step by step.
Most of the time, a bubble is nothing. But there are a handful of scenarios where pausing before you inject is the right call.
Check the liquid carefully if: the bubble is large enough to fill a significant portion of the cartridge window; the liquid looks milky, discoloured or contains visible floating particles; the pen has been stored outside the fridge for longer than the timeframe stated in the Patient Information Leaflet (the exact room-temperature window is specified there, and it matters, do not estimate); or the pen was dropped or damaged at any point.
In any of these cases, do not inject. Contact your pharmacist or prescriber first. At nume, aftercare support runs seven days a week, you can reach the team via the contact page and a clinician will advise you. If your pen looks genuinely wrong and you're not sure why, the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk also allows patients to report suspected product defects.
For general questions about the pen itself, storage, or what to do between doses, the nume FAQs carry answers to the questions our prescribers field most often. And if you'd like a clinical eye on your current treatment, you can speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.